论文信息 - Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma. - 字舞流文

Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma.

C. Heeschen | K. Olive | P. Sancho | Álvaro Curiel-García | Sladjana Zagorac | S. Courtois | Pilar Espiau-Romera | A. Royo-García | Isabel Villaoslada | Beatriz Parejo-Alonso